Leading manufacturer of Radiopharmaceuticals in North America
Leading manufacturer of Radiopharmaceuticals in North America
Radiopharma
Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercialising and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Live Through Nuclear MedicineTM on a global scale.
Radiopharmaceuticals Division
Jubilant Radiopharmaceuticals, stands at the forefront of the global radiopharmaceutical industry delivering innovative, reliable and sustainable nuclear diagnostic and therapeutic solutions that empower clinicians and elevate patient care. Guided by our commitment to Improving Lives through Nuclear Medicine, we uphold uncompromising quality standards, operate state‑of‑the‑art manufacturing facilities and continually invest in the development of advanced generic and novel nuclear agents.
Our mission is to enable earlier detection, more precise treatment, and ultimately, better outcomes for patients around the world. With on-shore manufacturing facility in Montreal and strong R&D capabilities to develop innovative new products, the Company has an efficient cost structure with in-house API manufacturing and robust supply chain management. It is a market leader in several products, including MAA, DTPA, Sulphur Colloid and HICON I-131®. It is innovation leader in the cardiac PET scan market in the US through its product Ruby-Fill®.
.png)
Radiopharmaceutical Networks
Jubilant Radiopharmacies is one of the largest and fastest-growing radiopharmaceutical networks in the United States, delivering comprehensive radiopharmaceuticals to hospitals and imaging centers nationwide. Built around PET, SPECT, and therapeutic radiopharmaceutical supply, our network of radiopharmacies and PET manufacturing facilities ensures consistent access to the products providers & patients rely on every day.
Through our open formulary model and commitment to operational excellence, we provide dependable, flexible support that empowers nuclear medicine departments to deliver high-quality, patient-centered care—on time, every time.
|
|